Skip to main content

CancerIQ

By Nathan Eddy | 02:31 pm | August 23, 2024
The Hennessy Institute for Cancer Prevention and Applied Molecular Medicine will utilize CancerIQ’s AI platform for personalized risk assessments and advanced early detection.
By Jessica Hagen | 01:22 pm | January 26, 2024
CancerIQ provides personalized care plans to help providers detect cancer early and prevent progression of the disease, says Feyi Ayodele, founder and CEO of CancerIQ.
By Emily Olsen | 03:31 pm | March 03, 2022
Also: Rupa Health raised $20 million for its lab test platform, and CancerIQ scooped up $14 million in Series B funding.
By Laura Lovett | 03:18 pm | August 24, 2020
Also IntelyCare makes slew of new hires and PixCell Medical adds to board chair.